Mohamed Ben-Eltriki

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Systematic Review

Radical Prostatectomy

Top Venues

Medicines (Basel, Switzerland)

Life (Basel, Switzerland)

Current issues in molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Ben-Eltriki, Erysa J Gayle, Jhoanne M Paras, Louisa Nyame-Addo, Manik Chhabra, Subrata Deb
Vitamin D in Melanoma: Potential Role of Cytochrome P450 Enzymes. Life (Basel, Switzerland) 14 (4) (2024)
Mohamed Ben-Eltriki, Erysa J Gayle, Jhoanne M Paras, Louisa Nyame-Addo, Manik Chhabra, Subrata Deb
Vitamin D in Melanoma: Potential Role of Cytochrome P450 Enzymes. Life (Basel, Switzerland) 14 (4) (2024)
Subrata Deb, Mohamed Ben-Eltriki, Hans Adomat, Mei Y Chin, Emma S Tomlinson Guns
Effect of Dexamethasone on Abiraterone Pharmacokinetics in Mice: Determined by LC/MS Analysis. Medicines (Basel, Switzerland) 10 (3) (2023)
Subrata Deb, Mohamed Ben-Eltriki, Hans Adomat, Mei Y Chin, Emma S Tomlinson Guns
Effect of Dexamethasone on Abiraterone Pharmacokinetics in Mice: Determined by LC/MS Analysis. Medicines (Basel, Switzerland) 10 (3) (2023)
Subrata Deb, Mohamed Ben-Eltriki, Hans Adomat, Mei Y Chin, Emma S Tomlinson Guns
Effect of Dexamethasone on Abiraterone Pharmacokinetics in Mice: Determined by LC/MS Analysis. Medicines (Basel, Switzerland) 10 (3) (2023)
Mohamed Ben-Eltriki, Erysa J Gayle, Noah Walker, Subrata Deb
Pharmacological Significance of Heme Oxygenase 1 in Prostate Cancer. Current issues in molecular biology 45 (5) (2023)
Subrata Deb, Mohamed Ben-Eltriki, Hans Adomat, Mei Y Chin, Emma S Tomlinson Guns
Effect of Dexamethasone on Abiraterone Pharmacokinetics in Mice: Determined by LC/MS Analysis. Medicines (Basel, Switzerland) 10 (3) (2023)
Juan Erviti, James Wright, Ken Bassett, Mohamed Ben-Eltriki, Ciprian Jauca, Luis Carlos Saiz, Leire Leache, Marta Gutiérrez-Valencia, Thomas L Perry
Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data. BMJ open 12 (12) (2022)
Juan Erviti, James Wright, Ken Bassett, Mohamed Ben-Eltriki, Ciprian Jauca, Luis Carlos Saiz, Leire Leache, Marta Gutiérrez-Valencia, Thomas L Perry
Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data. BMJ open 12 (12) (2022)
Juan Erviti, James Wright, Ken Bassett, Mohamed Ben-Eltriki, Ciprian Jauca, Luis Carlos Saiz, Leire Leache, Marta Gutiérrez-Valencia, Thomas L Perry
Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data. BMJ open 12 (12) (2022)
Juan Erviti, James Wright, Ken Bassett, Mohamed Ben-Eltriki, Ciprian Jauca, Luis Carlos Saiz, Leire Leache, Marta Gutiérrez-Valencia, Thomas L Perry
Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data. BMJ open 12 (12) (2022)
Juan Erviti, James Wright, Ken Bassett, Mohamed Ben-Eltriki, Ciprian Jauca, Luis Carlos Saiz, Leire Leache, Marta Gutiérrez-Valencia, Thomas L Perry
Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data. BMJ open 12 (12) (2022)
Mohamed Ben-Eltriki, Carolyn J Green, Malcolm Maclure, Vijaya Musini, Ken L Bassett, James M Wright
Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence. Pharmacology research & perspectives 8 (5) (2021)
Mohamed Ben-Eltriki, Subrata Deb, Gehana Shankar, Gray Meckling, Mohamed Hassona, Takeshi Yamazaki, Ladan Fazli, Mei Yieng Chin, Emma S Tomlinson Guns
Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer. Medicines (Basel, Switzerland) 8 (6) (2021)